Mono Pharmacare opened lower at -, compared with its previous close of ₹8.90. In the last trading session on 9 Oct 2026, the stock traded between - and -, with an average traded price of -. It showed a sideways intraday trend.
An investment of ₹10,000 made 4 years ago in Mono Pharmacare is now worth
₹ 2,923.00
resulting in a loss of
₹ 7,077.00 (70.77%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹8.90
Volume
-
Value Traded
-
1W Return
-0.58%
1M Return
3.49%
3M Return
-19.09%
6M Return
-26.45%
1Y Return
-59.27%
Market Cap (₹ Cr.)
16
PE Ratio
21.70
PB Ratio
0.50
Dividend Yield
-
ROE
2.32%
ROCE
7.47%
Book Value (₹)
17.86
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.58%
6 Week
-
1 Month
3.49%
3 Month
-19.09%
9 Month
-32.58%
Mono Pharmacare FY26 net profit falls 89% to ₹35.28 lakh
[Mono Pharmacare](https://scanx.trade/company/mono-pharmacare-ltd) reported an 89% decline in consolidated net profit to ₹35.28 lakh for FY26, with revenue decreasing to ₹16569.19 lakh. The Board approved the audited financial results, appointed auditors for FY27, and noted the resignation of the Company Secretary. The company also acknowledged an NSE notice regarding non-compliance with SEBI regulations.
2mo agoMono Pharmacare promoters declare no share encumbrance in FY26
Mono Pharmacare Limited's promoters and Persons Acting in Concert confirmed they did not create any encumbrance on shares during the financial year ended March 31, 2026. The disclosure was filed with the National Stock Exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
3mo agoMono Pharmacare pays ₹96760 fine for NSE non-compliance
Mono Pharmacare Limited paid a fine of ₹96760 imposed by the NSE for non-compliance with Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company addressed the delay following notices in May and June 2026 and has implemented corrective measures.
3mo agoMono Pharmacare schedules EGM to appoint auditor and independent director
Mono Pharmacare Limited has announced an EGM for June 30, 2026, to appoint M/s. R K Mergu & Co. as statutory auditor and Ms. Nirmala Ranawat as independent director. The meeting addresses a casual vacancy and the regularization of a director appointed in June 2026. Remote e-voting is open from June 27 to June 29.
4mo agoMono Pharmacare confirms SDD compliance for FY26
Mono Pharmacare Limited filed its SDD compliance certificate for FY26, confirming the capture of 7 UPSI events with zero non-compliance. The company maintained a secure, non-tamperable database as per SEBI PIT Regulations.
4mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 4 years ago in Mono Pharmacare is now worth
₹ 2,923.00
resulting in a loss of
₹ 7,077.00 (70.77%)
Note: Past profits do not guarantee future returns.
